BRAINSTORM CELL THERAPEUTICS INC. 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-112701
- Form type
- 10-Q
- CIK
- 0001137883
- Primary document
- https://www.sec.gov/Archives/edgar/data/1137883/000110465925112701/bcli-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BRAINSTORM CELL THERAPEUTICS INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-7.7M | - | - |
| Net Income | $-7.9M | - | - |
| Eps Basic | -0.91 | - | - |
| Eps Diluted | -0.91 | - | - |
| Cash And Equivalents | $5,000 | - | - |
| Total Assets | $1.4M | - | - |
| Total Liabilities | $9.1M | - | - |
| Shareholders Equity | $-7.7M | - | - |
| Operating Cash Flow | $-6.2M | - | - |